| Louisville Healthcare Llc | |
| 543 East Main Street, Louisville, Mississippi 39339 | |
| (662) 773-8047 | |
| Name | Louisville Healthcare Llc |
|---|---|
| Location | 543 East Main Street, Louisville, Mississippi |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 60 |
| Occupancy Rate | 77.17% |
| Medicare ID (CCN) | 255096 |
| Legal Business Name | Louisville Healthcare Llc |
| Ownership Type | For Profit - Individual |
| NPI Number | 1205823812 |
| Organization Name | CARE CENTER OF LOUISVILLE, LTD. |
| Address | 543 E Main St, Louisville, MS 39339 |
| Phone Number | 662-773-8047 |
News Archive
Cancer scientists led by Dr. John Dick at the Princess Margaret Cancer Centre have found a way to follow single tumour cells and observe their growth over time. By using special immune-deficient mice to propagate human colorectal cancer, they found that genetic mutations, regarded by many as the chief suspect driving cancer growth, are only one piece of the puzzle. The team discovered that biological factors and cell behaviour - not only genes - drive tumour growth, contributing to therapy failure and relapse.
Today, NORCAL Mutual Insurance Company of San Francisco, CA announced that it has entered into a definitive merger agreement for the acquisition of Medicus Insurance Holdings, Inc. of Austin, TX and its wholly-owned subsidiary, Medicus Insurance Company.
Motivated by the need to achieve cost-effective and high-quality care, the European healthcare industry is increasingly turning to computerised physician order entry (CPOE) systems.
Cancer researchers have applied a comprehensive set of analytical tools to lethal cases of metastatic prostate cancer, yielding a detailed map of the complex networks of interactions among genes and proteins that enable prostate cancer cells to proliferate and evade treatment.
In a small study that included 25 patients with hereditary hemorrhagic telangiectasia (a genetic disorder that leads to abnormalities of blood vessels) and severe liver involvement with this disease, patients who received the drug bevacizumab had improved cardiac output and a reduction in the duration and number of episodes of nose bleeds, a potentially life-threatening complication for patients with this disorder, according to a study in the March 7 issue of JAMA.
› Verified 3 days ago
| NPI Number | 1356587208 |
| Organization Name | LOUISVILLE HEALTHCARE LLC |
| Address | 543 East Main Street, Louisville, MS 39339 |
| Phone Number | 662-773-8047 |
News Archive
Cancer scientists led by Dr. John Dick at the Princess Margaret Cancer Centre have found a way to follow single tumour cells and observe their growth over time. By using special immune-deficient mice to propagate human colorectal cancer, they found that genetic mutations, regarded by many as the chief suspect driving cancer growth, are only one piece of the puzzle. The team discovered that biological factors and cell behaviour - not only genes - drive tumour growth, contributing to therapy failure and relapse.
Today, NORCAL Mutual Insurance Company of San Francisco, CA announced that it has entered into a definitive merger agreement for the acquisition of Medicus Insurance Holdings, Inc. of Austin, TX and its wholly-owned subsidiary, Medicus Insurance Company.
Motivated by the need to achieve cost-effective and high-quality care, the European healthcare industry is increasingly turning to computerised physician order entry (CPOE) systems.
Cancer researchers have applied a comprehensive set of analytical tools to lethal cases of metastatic prostate cancer, yielding a detailed map of the complex networks of interactions among genes and proteins that enable prostate cancer cells to proliferate and evade treatment.
In a small study that included 25 patients with hereditary hemorrhagic telangiectasia (a genetic disorder that leads to abnormalities of blood vessels) and severe liver involvement with this disease, patients who received the drug bevacizumab had improved cardiac output and a reduction in the duration and number of episodes of nose bleeds, a potentially life-threatening complication for patients with this disorder, according to a study in the March 7 issue of JAMA.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Cancer scientists led by Dr. John Dick at the Princess Margaret Cancer Centre have found a way to follow single tumour cells and observe their growth over time. By using special immune-deficient mice to propagate human colorectal cancer, they found that genetic mutations, regarded by many as the chief suspect driving cancer growth, are only one piece of the puzzle. The team discovered that biological factors and cell behaviour - not only genes - drive tumour growth, contributing to therapy failure and relapse.
Today, NORCAL Mutual Insurance Company of San Francisco, CA announced that it has entered into a definitive merger agreement for the acquisition of Medicus Insurance Holdings, Inc. of Austin, TX and its wholly-owned subsidiary, Medicus Insurance Company.
Motivated by the need to achieve cost-effective and high-quality care, the European healthcare industry is increasingly turning to computerised physician order entry (CPOE) systems.
Cancer researchers have applied a comprehensive set of analytical tools to lethal cases of metastatic prostate cancer, yielding a detailed map of the complex networks of interactions among genes and proteins that enable prostate cancer cells to proliferate and evade treatment.
In a small study that included 25 patients with hereditary hemorrhagic telangiectasia (a genetic disorder that leads to abnormalities of blood vessels) and severe liver involvement with this disease, patients who received the drug bevacizumab had improved cardiac output and a reduction in the duration and number of episodes of nose bleeds, a potentially life-threatening complication for patients with this disorder, according to a study in the March 7 issue of JAMA.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 31.62 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 19.1 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 49.21 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.03 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.05 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 26.97 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 21.35 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 19.89 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 13.57 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.54 | 95.98 |